Cases & Deals

Faron Pharmaceuticals places €3.1 million of Ordinary Shares on AIM

Clients Faron Pharmaceuticals Oy

Jones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection its €3.1 million (US$3.5 million) placement of Ordinary Shares on the Alternative Investment Market (AIM).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.